worldwide. The disease known as schistosomiasis, is the second most significant tropical
parasitic disease after malaria. Praziquantel is the only effective drug currently licensed for
schistosomiasis and there are concerns about resistance to the drug. There has been much
effort to develop vaccines against schistosomiasis to produce long-term protection in
endemic regions. Surface-associated proteins, and in particular, those expressed in the …